Evogene (EVGN NASDAQ) stock market data APIs
$1.1512
-0.06(-5.2%)
as of April 28, 2025
Evogene Financial Data Overview
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally. The company focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through its computational predictive biology (CPB) platform. It operates through three segments: Agriculture, Human Health, and other Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms. The Industrial Applications segment focuses on the development and commercialization of improved castor bean seeds for industrial uses. The company also provides medical cannabis products. Evogene Ltd. was incorporated in 1999 and is headquartered in Rehovot, Israel.
Prev. Close
1.1512
Open
1.0937
High
1.1681
Low
1.0853
52 wk Range
0.95-8.996
Market Cap
7 406 K
Shares Outstanding
6 672 K
Revenue
8 511 K
EPS
0.06
Beta
1.184
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Evogene data using free add-ons & libraries
Get Evogene Fundamental Data
Evogene Fundamental data includes:
- Net Revenue: 8 511 K
- EBITDA: -20 503 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-03-05
- EPS/Forecast: -0.725
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Evogene News
New
Why Evogene Ltd. (EVGN) Soared on Monday
We recently compiled a list of the 10 Micro-, Small-Cap Companies Lead Monday's Charge.In this article, we are going to take a look at where Evogene Ltd. (NASDAQ:EVGN) stands against the other stocks....
ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants
More than one dozen novel microbes identified for row crops suffering from extreme weather conditions TEL AVIV and REHOVOT, Israel, July 17, 2024 /PRNewswire/ -- ICL (NYSE: ICL) (TASE: ICL), a leadi...
Evogene Ltd. (NASDAQ:EVGN) Q4 2023 Earnings Call Transcript
Evogene Ltd. (NASDAQ:EVGN) Q4 2023 Earnings Call Transcript March 7, 2024 Evogene Ltd. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here)...
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides
REHOVOT, Israel, March 6, 2024 /PRNewswire/ -- AgPlenus Ltd., a global leader in designing and developing novel sustainable crop protection products and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TA...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
